AF
IMCR icon

Allworth Financial’s Immunocore IMCR Stock Holding History

Allworth Financial’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-86
Closed -$2.59K – 5287
2026
Q1 		$2.59K Hold
86
– – ﹤0.01% 4261
2025
Q4 		$2.99K Hold
86
– – ﹤0.01% 3965
2025
Q3 		$3.13K Buy
+86
New +$2.92K ﹤0.01% 3798

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Allworth Financial's IMCR Position: Q2 2026 in Review

Allworth Financial sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 86 shares — an estimated $2.59K sold.

Allworth Financial first reported a position in IMCR in Q3 2025 and held it in 3 quarters. The position peaked at $3.13K in Q3 2025. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Allworth Financial reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Allworth Financial sold 86 Immunocore shares in Q2 2026, an estimated $2.59K.
  • Allworth Financial first reported a position in Immunocore in Q3 2025 and held it in 3 quarters.
  • Allworth Financial's Immunocore position peaked at $3.13K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.